Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma

Measurement of health-related quality of life was integrated into a randomized trial (NMSG 4/90) comparing melphalan/prednisone to melphalan/prednisone + interferon α-2b in newly diagnosed multiple myeloma. One of the aims of the study was to assess the prognostic significance of quality-of-life scores, using the EORTC QLQ-C30 questionnaire. Univariate analysis showed a highly significant association with survival from the start of therapy for physical functioning as well as role and cognitive functioning, global quality of life, fatigue and pain. In multivariate analysis, physical functioning and W.H.O. performance status were independent prognostic factors ( P values=0.001 for both) when analysed in a Cox regression model with the somatic variables β-2 microglobulin, skeletal disease and age. The best prediction for survival from the start of therapy was obtained by combining the β-2 microglobulin and physical functioning scores in a variable consisting of three risk factor levels with an estimated median survival of 17, 29 and 49 months, respectively. At a 12 months landmark analysis, the relative risk for patients with physical functioning score 0–20 v 80–100 was 5.63 (99% CI 2.76–11.49), whereas the relative risk for patients without an objective response to chemotherapy compared to those with at least a minor response was 2.32 (99% CI 1.44–3.74). Quality-of-life assessment may be an independent and valuable addition to the known prognostic factors in multiple myeloma.     

重庆市城市居民1991～2000年死亡损失生命年分析

目的：研究重庆市城市居民20世纪90年代疾病所致早死的生命损失。方法：用死亡损失生命年YLLs为测量单位，计算不同性别、不同社区的死因别标化YLLs率，及分析1991～2000年死因别标化YLLs率的变化趋势。结果：非传染性疾病标化YLLs率为42.58‰，占全死因的82.76%，其中，恶性肿瘤标化YLLs率为12.80‰，占30.06%，脑血管疾病标化YLLs率 6.62‰，占15.55%，呼吸系统疾病标化YLLs率5.77‰，占13.55%，心脏病标化YLLs率4.38‰，占10.29%；意外死亡标化YLLs率为7.59‰，占全死因的14.75%；传染病、妇科及围产期疾病标化YLLs率为1.28‰，仅占2.49%。在社区之间，死因别标化YLLs率存在明显差异。结核病和精神病标化YLLs率曾出现上升趋势。结论：非传染性疾病已成为该城市居民的主要疾病负担，结核病防治不能放松，精神卫生工作急待开展。     

青年急性冠脉综合征冠脉造特点及随访

目的:探讨青年急性冠状动脉综合征(ACS)冠状动脉(冠状)造影特点及其与远期心脏事件的关系。方法:比较青年ACS与老年ACS患者冠脉病变程度、范围,并进行心脏事件随访。结果:78例青年ACS患者有冠脉病变74例(94.9％),单支病变46例(58.9％);171例老年ACS患者有冠脉病变166例(97.1％),单支病变41例(23.9％)。平均随访9个月,青年ACS患者发生心脏事件者10例(12.8％),其中心绞痛再入院6例(7.7％);老年ACS患者发生心脏事件者47例(27.5％),其中心绞痛再入院30例(17.5％),两组比较差异有显著性(P<0.05)。结论:ACS患者冠状动脉粥样硬化青年时期之前已经发生,ACS预后与冠脉病变程度和年龄呈正相关。     

老年慢性病患者常见症状与生存质量的相关性研究

目的 探讨老年慢性病患者常见症状间的相互关系及其对生存质量的影响,以寻找提高其生存质量的护理对策.方法 采用焦虑自评量表、老年人抑郁量表、SF-36量表对230例老年慢性病患者进行常见症状及生存质量调查,并分析各种症状间的关系以及症状与生存质量的相关性.结果 老年慢性病患者生存质量八大项目得分偏低.常见躯体症状包括躯体疼痛、头晕、疲乏、睡眠障碍发生率依次为25.73%、33.80%、25.00%、22.05%.常见心理症状焦虑和抑郁得分为38.35±7.26、8.71±5.21.且各种常见症状之间呈正相关(r=0.80～0.612,P<0.05),各种常见症状与生存质量呈负相关(r=-0.175～-0.623,P<0.05).结论 在老年慢性病患者居家护理过程中,须及时采取积极有效护理措施控制或减轻病人症状,且躯体症状护理与心理护理应并重,措施实施与原因排查应同步,主要症状与次要症状要兼顾,以提高其生存质量.     

TAXUS支架治疗急性冠状动脉综合症的疗效评价

目的评价紫杉醇洗脱冠状动脉支架(TAXUStmBoston公司产品)应用于急性冠状动脉综合症病人的临床疗效及安全性。方法自2003年5月至2004年12月接受TAXUS支架治疗的94例急性冠状动脉综合症患者,观察术后即刻效果、术后6个月心脏性死亡、心肌梗塞、再次血管重建及冠状动脉造影复查情况。病例中包括ST段抬高的急性心肌梗塞27例,非ST段抬高的急性心肌梗死8例,不稳定心绞痛59例。结果支架植入成功率为99%,术中和随访期间无死亡,术后1例出现亚急性血栓,1例晚期血栓致心肌梗塞,另有5例随访中进行了血管重建术,6个月主要心脏不良事件(MACE)发生率7.4%。术后6～7个月23例的冠状动脉造影复查再狭窄率为13.0%(支架内为8.6%),靶病变重建率为2.7%。结论应用TAXUS支架治疗急性冠状动脉综合症是安全和有效的,支架内再狭窄率明显低于普通金属支架。     

Quality of life after total mesorectal excision for rectal cancer

BACKGROUND: After total mesorectal excision for rectal cancer, many surgeons try to avoid an abdominoperineal resection (APR) by performing a transanally double stapled low colo-rectal anastomosis (LRA), frequently without a pouch. This policy is mainly based on the assumption that the quality of life after such LRA is higher than after APR. It has been suggested that a better functional outcome and therefore a higher quality of life might be achieved by a colo-anal J-pouch anastomosis (CPA). The aim of this study was to assess quality of life among disease-free survivors after APR, LRA and CPA. METHODS: The charts of 301 consecutive patients who had undergone surgery for cancer in the middle or lower third of the rectum were analysed. Two hundred four patients were eligible for inclusion. The quality of life among these patients was assessed using one generic (EQ-5D) and two disease-specific questionnaires (EORTC QLQ-C30 and EORTC QLQ-CR38). RESULTS: The response rate was 82%. The median follow-up was 31 months. Overall, quality of life was good but CPA patients had better quality of life scores than APR and LRA patients. This difference was not only due to the better functional outcome but also to the lower incidence of disturbed micturition and sexual problems in the CPA group. CONCLUSION: The quality of life after colo-anal J-pouch anastomosis is better than after abdominoperineal resection (APR) and low colo-rectal anastomosis (LRA). The quality of life after APR is similar to that after LRA.     

对血脂异常人群实施生活方式干预后的观察

目的：探讨生活方式治疗在血脂异常人群中的作用，观察其效果。方法：100例在体检中发现的血脂异常者，随机分为实验组和对照组，对实验组进行生活方式治疗，对照组未进行生活方式治疗，两组均未使用药物降脂，随访6—9个月，平均7．6个月，复查血脂，以检测血脂结果是否达到目标值进行对比。结果：经统计学处理，两组血脂在达到目标值方面存在显著性差异（p〈0．01）。结论：生活方式治疗对血脂异常人群具有明显的防治作用。